Home » Newsletters » BioWorld Science

BioWorld Science

July 25, 2001

View Archived Issues

Investigational immunotherapy for Alzheimer's disease enters phase IIa

Diversa and IntraBiotics discontinue antimicrobial alliance

Cell Matrix awarded grants for development of novel antiangiogenesis products

Adaptive Screening offers new approach to drug discovery

Second-quarter development progress reported by Sepracor

JNK inhibitor appears to have disease-modifying activity in rheumatoid arthritis

Role of dipeptidyl-peptidase IV in GIP metabolism, biological activity

FDA advisory committee to review IntraDose

Corvas provides status report for rNAPc2

Pilot studies suggest that EPA may be a novel therapeutic option in schizophrenia

Neurocrine Biosciences and GSK establish collaboration for CRF receptor antagonists

QLT and Novartis Ophthalmics expand verteporfin codevelopment agreement

Methotrexate-albumin conjugate may be particularly useful against prostate cancer, sarcomas

ProChon and MorphoSys identify new class of antibody

Chlamydia candidate vaccine reveals potential to protect against STD-related infertility

Inhibitors of HIV fusion and entry a focus of interest at recent conference

Abgenix and CuraGen make progress in development of novel antibody drug targets

Survival prolonged in tumor-bearing mice treated with GTI-2040

Lovastatin reduces coronary event risk in subjects with elevated C-reactive protein levels

Use of BTK inhibitor LFM-A13 for inhibiting platelet aggregation

New antitumor compounds in development at Pharmacia

Abbott claims ketolide antibacterial agents in recent patent

Preparation of dihydroquinoline derivatives and use as analgesics

Heterocyclic compounds from Takeda may have therapeutic potential in diabetic neuropathy

Antifungal chromone derivatives reported by Toyama

Kyorin's new PPAR activators reportedly useful in diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...